Goodbody Health Limited GDBYF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

44/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Goodbody Health Limited (GDBYF) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 41/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score

44/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✓

健康

100/100

Debt-to-Equity & liquidity

→ Health

护城河

50/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — GDBYF

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.07

每股账面价值$0.00

每股营收$0.49

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2012	$-0.52	$0.00	$-41.51K	-
2013	$-0.12	$0.00	$-36.52K	-
2014	$-0.16	$0.00	$-49.87K	-
2015	$-0.35	$0.00	$-179K	-
2016	$-0.08	$0.00	$-40.4K	-
2017	$-0.18	$0.00	$-175.46K	-
2018	$-0.17	$452.42K	$-349K	-77.1%
2019	$-0.48	$1.45M	$-3.8M	-262.1%
2020	$-0.29	$1.99M	$-4.66M	-233.7%
2021	$-0.07	$17.06M	$-2.31M	-13.6%